TegoScience Inc. (KOSDAQ:191420)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,560
-220 (-1.72%)
At close: Apr 2, 2026
Market Cap100.56B -19.7%
Revenue (ttm)5.94B -12.1%
Net Income-7.01B
EPS-876.00
Shares Out8.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,326
Average Volume11,654
Open13,000
Previous Close12,780
Day's Range12,190 - 13,000
52-Week Range11,090 - 20,250
Beta0.87
RSI44.35
Earnings DateNov 14, 2025

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 191420
Full Company Profile

Financial Performance

Financial Statements